Zoryve’s regulatory and commercial success, together with pipeline progress, supports Arcutis Biotherapeutics’ positive Q2 ...

Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...

In July 2025, Regeneron Pharmaceuticals organized a study is researching an experimental drug called REGN5381 (called "study ...